Not currently recruiting at UCSD
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Replimune Inc.
- ID
- NCT03767348
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 340 study participants
- Last Updated